Patents by Inventor Joseph Auerbach
Joseph Auerbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20050085680Abstract: The present invention provides a method for low cost and non-toxic disposal/destruction of process waste containing; metals, metal salts and solvents (entrainment), which is easy and safe to handle and meets current effluent standards. According to one embodiment of the present invention the method is useful in the manufacture of amitriptyline hydrochloride and cyclobenzaprine hydrochloride.Type: ApplicationFiled: September 1, 2004Publication date: April 21, 2005Inventors: Joseph Auerbach, Junior Francis, Ming-Huei Yue
-
Patent number: 5932767Abstract: Protriptyline can be prepared from 5-dihydrodibenzocycloheptatriene, by deprotonation, followed by reaction at low temperatures with 1,3-bromochloropropane to give the 5-(chloropropyl)-dibenzocycloheptatriene, which is reacted with methylamine in a displacement reaction to give the protriptyline product.Type: GrantFiled: December 22, 1997Date of Patent: August 3, 1999Assignee: Merck & Co., Inc.Inventors: Robert S. Hoerrner, Joseph Auerbach, John Carolan
-
Patent number: 5618944Abstract: This invention relates to compounds, including 5-chloro-2-[2-[[(4-methylphenyl)sulfonyl]oxy]ethyl]-7-[2,4,6-trimethylphen yl)methoxy]anthra[1,9-cd]pyrazol-6(2H)-one and analogs thereof, which are useful as intermediates for the synthesis of anthrapyrazolone anticancer agents, including losoxantrone. This invention also relates to methods for the synthesis of anthrapyrazolone anticancer agents, including losoxantrone.Type: GrantFiled: January 10, 1995Date of Patent: April 8, 1997Assignee: The DuPont Merck Pharmaceutical CompanyInventors: Lin-Hua Zhang, Joseph Auerbach
-
Patent number: 5393886Abstract: This invention relates to compounds, including 5-chloro-2-[2-[[(4-methylphenyl)sulfonyl]oxy]ethyl]-7-[2,4,6-trimethylphen yl)methoxy]anthra[1,9-cd]pyrazol-6(2H)-one and analogs thereof, which are useful as intermediates for the synthesis of anthrapyrazolone anticancer agents, including losoxantrone. This invention also relates to methods for the synthesis of anthrapyrazolone anticancer agents, including losoxantrone.Type: GrantFiled: October 25, 1993Date of Patent: February 28, 1995Assignee: The Du Pont Merck Pharmaceutical CompanyInventors: Lin-Hua Zhang, Joseph Auerbach
-
Patent number: 5310917Abstract: 4-Substituted-1,4-dihydropyridines are prepared by a cycloaddition reaction in which the cyclization is driven to completion, after thermal reaction, by addition of an acid. Felodipine, a vasodilator, is prepared by a cycloaddition reaction of ethyl 3-aminocrotonate with a suitably substituted dichlorobenzylidine under reaction conditions whereby the product crystallizes out of the reaction solution and may be directly isolated by filtration.Type: GrantFiled: July 28, 1992Date of Patent: May 10, 1994Assignee: Merck & Co., Inc.Inventor: Joseph Auerbach
-
Patent number: 5248817Abstract: A novel procedure for bromination of aromatic moieties utilizes N-bromosuccinimide or dibromodimethylhydantoin in an aqueous alkali medium. The bromination procedure is employed for the preparation of an intermediate used in the preparation of remoxipride, an antipsychotic compound.Type: GrantFiled: July 8, 1992Date of Patent: September 28, 1993Assignee: Merck & Co., Inc.Inventors: Joseph Auerbach, Steven A. Weissman
-
Patent number: 4792568Abstract: This invention relates to new lipoxygenase inhibitors possessing anti-inflammatory and anti-allergic properties. The present new compounds are of the formula: ##STR1## and salts thereof; wherein, R is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, lower aralkyl, phenyl, naphthyl, or a nitrogen oxygen or sulfur heterocyclic; andY.sub.1 and Y are independently hydrogen, lower alkyl, hydroxy, lower alkoxy, aryloxy, lower aralkoxy, aryl, lower aralkyl, carboxy, lower carbalkoxy, lower carbaralkoxy, carbaryloxy, formyl, or alkyl, alkenyl or alkynyl containing up to 6 carbon atoms in the principal chain and up to a total of 10 carbon atoms;provided that when Y and Y.sub.1 are both hydrogen or when Y.sub.1 is hydrogen and Y is CHO, the R is other than hydrogen, unsubstituted phenyl, or lower alkyl.Type: GrantFiled: April 14, 1986Date of Patent: December 20, 1988Assignee: Rorer Pharmaceutical CorporationInventor: Joseph Auerbach
-
Patent number: 4644009Abstract: Provided are new compounds having valuable therapeutic activity. These compounds are of the formula: ##STR1## and salts thereof, whereinX=O, S or NR.sub.2 ;Z=(CHR.sub.3).sub.n C(R.sub.3))OH)--, ##STR2## --CH.sub.3 .dbd.CH.sub.3 CR.sub.3 (OH)--, or --(CHR.sub.3).sub.n', M=--O--, --S--, or ##STR3## Z.sub.1 is an alkylene chain of 0-5 carbon atoms in the principal chain and a total of 7 carbon atoms;R.sub.1 is H, phenyl, naphthyl or a sulfur, nitrogen or oxygen-heterocyclic ring;R.sub.2 is H, alkyl, aryl or aralkyl;R.sub.3 is H or CH.sub.3 ;n=0-5; andn'=1-5.Type: GrantFiled: October 29, 1984Date of Patent: February 17, 1987Assignee: USV Pharmaceutical CorporationInventors: Fu-chih Huang, Joseph Auerbach
-
Patent number: 4570001Abstract: Compounds of the structure ##STR1## wherein R is hydrogen, lower alkyl containing 1 to 5 carbon atoms, cycloalkyl containing 3 to 7 carbon atoms, phenyl or phenyl substituted with halogen, trifluoromethyl, or lower alkyl or lower alkoxy having 1 to 4 carbon atoms and R.sub.1 is hydrogen, lower alkyl having 1 to 4 carbon atoms, phenyl or phenyl lower alkyl wherein the lower alkyl has 1 to 4 carbon atoms, are formed by cyclizing a compound of the structure ##STR2## wherein R and R.sub.1 are as defined above, in the presence of an acid.Type: GrantFiled: April 27, 1984Date of Patent: February 11, 1986Assignee: Science Union et CieInventors: Joseph Auerbach, Martin Kantor
-
Patent number: 4477675Abstract: The process of preparing a compound of the formula: ##STR1## wherein, Y and Z are each H, alkyl, halo, alkoxy, trifluoromethyl, hydroxy, alkanoyloxy, or alkanoylamino;X is F, Cl, Br, or NR.sub.1 R.sub.2 wherein R.sub.1 and R.sub.2 are each hydrogen, alkyl, alkynyl, alkenyl, cycloalkyl, aryl or aralkyl; andR is H, alkyl, cycloalkyl, or aralkyl; which comprises the step of oxidation of the corresponding 3-desoxy compound.Type: GrantFiled: September 7, 1982Date of Patent: October 16, 1984Assignee: USV Pharmaceutical CorporationInventors: Joseph Auerbach, Frederick A. Golec, Jr.
-
Patent number: 4331600Abstract: Compounds of the formula ##STR1## wherein, Y and Z are each H, alkyl, halo, alkoxy, trifluoromethyl, hydroxy, alkanoyloxy, or alkanoylamino;X is F, Cl Br or NR.sub.1 R.sub.2 in which R.sub.1 and R.sub.2 are each hydrogen, alkyl, alkenyl, alkynyl, aryl, aralkyl or cycloalkyl; andR is H, alkyl, cycloalkyl or aralkyl; and salts thereof.The compounds have utility as anti-hypertensive and diuretic agents and as intermediates for the preparation of other anti-hypertensive and diuretic agents.Type: GrantFiled: October 31, 1980Date of Patent: May 25, 1982Assignee: USV Pharmaceutical CorporationInventors: Frederick A. Golec, Jr., Joseph Auerbach
-
Patent number: 4258059Abstract: Compounds of the formula ##STR1## wherein: Ar and Ar' are independently alicyclic aryl or heterocyclic aryl groups;R.sub.1 is a substituent replacing a hydrogen on the ring and is independently hydroxy, alkyl, alkoxy, halogen, nitro, amino, monoalkyl-amino, dialkyl-amino, sulfhydryl, alkylmercapto, sulfonamido, carboxy, carbalkoxy, or trihalomethyl;n is an integer from 0 to 5 inclusive;R.sub.2 and R.sub.3 are independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, phenyl, or cycloalkyl-alkyl; andR.sub.4 and R.sub.5 are independently halogen or trihalomethyl, with the proviso that when both Ar and Ar' are phenyl and n is 0, both R.sub.2 and R.sub.3 are not hydrogen.Type: GrantFiled: June 21, 1979Date of Patent: March 24, 1981Assignee: USV Pharmaceutical CorporationInventors: Joseph Auerbach, Martin L. Kantor